USA - NYSE:PEAK - US42250P1030 - REIT
ChartMill assigns a Buy % Consensus number of 78% to PEAK. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-04 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-01-30 | Deutsche Bank | Initiate | Hold |
| 2024-01-12 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2023-10-31 | Wedbush | Reiterate | Neutral -> Neutral |
| 2023-10-11 | Exane BNP Paribas | Initiate | Underperform |
| 2023-10-05 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2023-10-03 | Wedbush | Initiate | Neutral |
| 2023-09-07 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-25 | Barclays | Maintains | Overweight -> Overweight |
| 2023-06-15 | Mizuho | Reiterate | Buy -> Buy |
| 2023-06-15 | Citigroup | Reiterate | Neutral -> Neutral |
| 2023-06-12 | Mizuho | Reiterate | Buy -> Buy |
| 2023-05-04 | RBC Capital | Maintains | Sector Perform |
| 2023-04-24 | Mizuho | Upgrade | Neutral -> Buy |
| 2023-04-20 | Wells Fargo | Initiate | Equal-Weight |
| 2023-04-19 | Wells Fargo | Initiate | Equal-Weight |
| 2023-04-06 | Citigroup | Downgrade | Buy -> Neutral |
| 2023-03-31 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2023-03-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-02-28 | Citigroup | Maintains | Buy |
| 2023-02-10 | Barclays | Maintains | Overweight |
| 2023-01-03 | Jefferies | Upgrade | Hold -> Buy |
| 2022-12-14 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2022-11-21 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2022-11-01 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-28 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2022-09-09 | Barclays | Maintains | Overweight |
| 2022-08-31 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-29 | Mizuho | Maintains | Neutral |
| 2022-07-15 | Morgan Stanley | Maintains | Equal-Weight |
22 analysts have analysed PEAK and the average price target is 22.19 USD. This implies a price increase of 29.74% is expected in the next year compared to the current price of 17.1.
The consensus rating for HEALTHPEAK PROPERTIES INC (PEAK) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering HEALTHPEAK PROPERTIES INC (PEAK) is 22.